← Back
$ACRV All transactions

Acrivon Therapeutics, Inc.

A

$ Value

$7.0M

Shares

3,888,888

Price

$2

Filed

Apr 23

Insider

Name

RA CAPITAL MANAGEMENT, L.P.

Title

CIK

0001346824

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-04-22

Code

A

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

11,803,094

Footnotes

Held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. | Held directly by Nexus Fund II.

Filing Info

Accession No.

0001231919-26-000396

Form Type

4

Issuer CIK

0001781174

RA CAPITAL MANAGEMENT, L.P.'s History

Date Ticker Type Value
2026-04-22 ACRV A $7.0M
2026-04-20 VOR $2.7M
2026-04-17 VOR $7.5M
2026-04-15 VOR $859K
2026-04-14 VOR $2.5M
2026-04-13 VOR $8.6M
2026-04-10 VOR $13K
2026-04-09 VOR $2.2M
2026-04-08 VOR $5.8M
2026-04-08 VOR $2.2M

Other Insiders at ACRV (90d)

Insider Bought Sold Last
Miller Mary
Chief Legal Officer
2026-04-17